Recent advances in the management of non-small cell lung cancer.
Recent advances in the management of non-small cell lung cancer.
复制标题
DOI：
10.12688/f1000research.11471.1
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Nana-Sinkam P
中科院分区：
文献类型：
--
作者：
Shojaee S;Nana-Sinkam P
肺癌是男性和女性癌症相关死亡的头号原因。然而，在过去的几年里，我们看到了改善的结果，这在很大程度上归功于早期发现，烟草控制的努力增加，手术方法的改进以及新型靶向治疗的发展。目前，在临床实践中有几种新的疗法，包括靶向可操作突变的疗法和最近的免疫抑制剂。免疫疗法是根除这种致命疾病的最重要的一步。鉴于肺癌管理的不断变化，我们在这里概述了非小细胞肺癌管理的最新进展。
Lung cancer is the number one cause of cancer-related death in both men and women. However, over the last few years, we have witnessed improved outcomes that are largely attributable to early detection, increased efforts in tobacco control, improved surgical approaches, and the development of novel targeted therapies. Currently, there are several novel therapies in clinical practice, including those targeting actionable mutations and more recently immunotherapeutic agents. Immunotherapy represents the most significant step forward in eradicating this deadly disease. Given the ever-changing landscape of lung cancer management, here we present an overview of the most recent advances in the management of non-small cell lung cancer.